The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 18, 2010

Filed:

Mar. 31, 2006
Applicants:

Eun Young Song, Seoul, KR;

Jae Wha Kim, Seoul, KR;

Hee Gu Lee, Daejeon, KR;

Jong Seok Lim, Seoul, KR;

Seung Chul Choi, Daejeon, KR;

MI Young Cho, Daejeon, KR;

Kyoung Eun Baek, Daejeon, KR;

Jin Sook Kim, Daejeon, KR;

Jong Tae Kim, Daejeon, KR;

DO Young Yoon, Seoul, KR;

Dur Han Kwon, Daejeon, KR;

Mi-young Park, Daejeon, KR;

Young IL Yeom, Daejeon, KR;

Yong-kyung Choe, Daejeon, KR;

Young-jun Kim, Daejeon, KR;

Inventors:

Eun Young Song, Seoul, KR;

Jae Wha Kim, Seoul, KR;

Hee Gu Lee, Daejeon, KR;

Jong Seok Lim, Seoul, KR;

Seung Chul Choi, Daejeon, KR;

Mi Young Cho, Daejeon, KR;

Kyoung Eun Baek, Daejeon, KR;

Jin Sook Kim, Daejeon, KR;

Jong Tae Kim, Daejeon, KR;

Do Young Yoon, Seoul, KR;

Dur Han Kwon, Daejeon, KR;

Mi-Young Park, Daejeon, KR;

Young Il Yeom, Daejeon, KR;

Yong-Kyung Choe, Daejeon, KR;

Young-Jun Kim, Daejeon, KR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12P 21/08 (2006.01); C07K 16/00 (2006.01); C12N 5/06 (2006.01); C12N 5/16 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to a monoclonal antibody specific for N-myc downstream regulated gene 2 (NDRG 2) protein, a cell line producing the monoclonal antibody, a method for measuring a quantity and quality of NDRG 2 protein, and a protein chip using the same. In the present invention, NDRG 2, a cancer-related factor is specifically expressed in dendritic cells differentiated from a monocyte of human peripheral blood. Accordingly, the monoclonal antibody specific for the NDRG 2 protein, the protein chip comprising the same and the method for measuring a quantity and quality of the NDRG 2 protein by using the same can be applied to elucidate characteristics of the dendritic cell and perform a research on the NDRG 2. Therefore, the present invention may help clinically to investigate and treat intractable diseases and cancers using the dendritic cell.


Find Patent Forward Citations

Loading…